Disease / condition

Osteoporosis clinical trials

Free access to 658 studies·10+ countries·Updated daily77 recruiting
658
Total trials
10+
Countries
10+
Sponsors
77
Recruiting
By phase
N/A310
Phase 478
Phase 373
Phase 161
Phase 258
By status
Completed400
Recruiting77
Unknown76
Not yet recruit...54
Terminated23
Top countries
United States of America135
Japan74
China72
Canada24
United Kingdom20
Top sponsors
Eli Lilly and Comp...21
Merck Sharp & Dohm...18
GlaxoSmithKline15
Novartis Pharmaceu...11
Amgen10
Recent trials
Latest clinical trials for Osteoporosis
NCT06372158Recruiting
Effects of Liposomal Encapsulation on Calcium Powder Absorption and Metabolism
National Yang Ming UniversityTaiwan
NCT06332014·Phase 4Not yet recr...
Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China
Amgen
NCT06270758Recruiting
Clinical Validation of BBCT-hip
Istituto Ortopedico RizzoliItaly
NCT06264609·Phase 4Enrolling by...
Precision Medicine Approach for Osteoporosis - Follow Up Study
Hartmut Malluche, MDUnited States of America
NCT06154187·Phase 3Not yet recr...
Study to Evaluate the Efficacy and Safety of PBK_L2201 in Postmenopausal Women With Osteoporosis
Pharmbio Korea Co., Ltd.South Korea
NCT06118905·Phase 4Not yet recr...
Preserving Geriatric Muscle With an Osteoporosis Medication
Susan L. Greenspan
NCT06110442Recruiting
Opportunistic Fragility Fracture Risk Estimates From Radiographs
University of ExeterUnited Kingdom
NCT06041789·Phase 2Not yet recr...
Effect of Acetylcholinesterase Inhibitors on Bone Metabolism
Duke UniversityUnited States of America
NCT06059222·Phase 4Recruiting
The Optimised Use of Romozosumab Study
University of AarhusDenmark
NCT05937945Not yet recr...
Studying Patient Experiences in Osteoporosis Clinical Trials
Power Life Sciences Inc.United States of America
NCT05930704·Phase 1Recruiting
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-2017 Injection in Postmenopausal Women
Suzhou Suncadia Biopharmaceuti...China
NCT05936177Recruiting
Brief Osteoporosis Education to Increase Awareness in Middle Aged and Elderly.
Selkin Yılmaz MulukTurkey
NCT05906147Recruiting
Health ImprOvement Program of Bone in China
Second Xiangya Hospital of Cen...China
jRCT2031230117Recruiting
Untitled Trial
ID Pharma Co., Ltd.India
ANZCTR12623000520639·Phase 1Not yet recr...
A Study to Compare the Pharmacokinetic, Pharmacodynamics, safety, Tolerability and Immunogenicity of BP16 versus Prolia (US and EU approved) in Healthy male Volunteers.
CuraTeQ Biologics Private Ltd.Australia
NCT05889104Not yet recr...
Effect of Progressive Loading Protocol on Bone Mineral Density
Imam Abdulrahman Bin Faisal Un...
NCT05851131Not yet recr...
Surveying Knowledge, Attitudes, and Practices of Primary Care Physicians in Turkey Regarding Osteoporosis Management.
Uskudar State Hospital
NCT05823558Not yet recr...
Comparison of Lumbar Muscle Thickness Measurements in Osteoporotic and Osteopenic Patients
Sisli Hamidiye Etfal Training ...
NCT05721118Not yet recr...
Diagnostic Performances of Mandibular CBCT in Osteoporosis
Nantes University Hospital
jRCT1051220150Not yet recr...
Untitled Trial
About this record

Access comprehensive clinical trial information for Osteoporosis through Pure Global AI's free database. This collection includes 658 clinical trials across multiple phases including N/A, Phase 4, Phase 3. Currently, 77 trials are actively recruiting participants.

Research for Osteoporosis is being conducted in United States of America, Japan, China and 7+ other countries. Leading sponsors include Eli Lilly and Company and Merck Sharp & Dohme LLC. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 658 clinical trials studying Osteoporosis, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Eli Lilly and Company, Merck Sharp & Dohme LLC, GlaxoSmithKline, among others.